Consonance Capital Management LP 13D and 13G filings for OXFORD IMMUNOTEC GLOBAL PLC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-17 3:14 pm Sale |
2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD |
Consonance Capital Management LP | 0 0.000% |
-6,058,505![]() (Position Closed) |
Filing |
2021-02-16 4:19 pm Purchase |
2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD |
Consonance Capital Management LP | 6,058,505 11.000% |
6,058,505![]() (New Position) |
Filing |
2021-02-16 2:39 pm Sale |
2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD |
Consonance Capital Management LP | 0 0.000% |
-2,363,724![]() (Position Closed) |
Filing |